Furthermore, scientific investigations have revealed that lncRNA H19 influences tumor cell proliferation, metastasis, and apoptosis inhibition and that up-regulation of lncRNA H19 stimulates cancer cell resistance to chemotherapy and radiotherapy; thus, H19 not only provides new biomarkers for molecular diagnostics, but also serves as a new target for anti-tumor therapy (105–107). Here, H19 is linked to cancer.